Global Health (MEDANTA) Q4 24/25 earnings summary

Executive summary

• Flagship hospital in Gurugram celebrated its 15th anniversary and was ranked India's best private hospital by Newsweek for the sixth consecutive year.

• Achieved 13% year-over-year revenue growth in FY2025, driven by increased patient volumes and bed capacity expansion.

• Completed merger of Medanta Holdings Private Limited (MHPL) with Global Health Limited, incurring a one-time exceptional expense of INR 499 million.

• Announced first-ever dividend of 25% (INR 0.50 per share) for shareholders.

• Added 100+ doctors, invested in advanced technology, and appointed Dr. Pankaj Dhamija as Hospital Director, Gurugram Unit.

Financial highlights

• FY2025 consolidated income was INR 37,714 million, up 13% year-over-year; EBITDA reached INR 9,562 million, up 9% year-over-year, with a margin of 25.4%.

• Adjusted profit after tax was INR 5,186 million, up 9% year-over-year, with a margin of 13.8%.

• Q4 FY2025 income was INR 9,542 million, up 14% year-over-year; EBITDA was INR 2,476 million, up 20% year-over-year, with a margin of 26%.

• Net cash position of INR 8,123 million as of March 31, 2025.

• Standalone and consolidated profit after tax for FY25 were INR 4,615.28 million and INR 4,813.18 million, respectively.

Outlook and guidance

• Plans to add approximately 1,000 beds in the next two years and another 2,000 beds over the next three to four years, with over INR 3,500 crore capex planned for the next five years.

• Noida facility (300–550 beds) expected to be operational in Q2 FY2026; Ranchi 110-bed hospital to be operational in Q1 FY2026.

• Mumbai, Pitampura, and Guwahati projects in advanced planning or land acquisition stages, with construction timelines of about three years.

• Focus on expanding into high-growth markets and enhancing clinical capabilities.